Clinical Trial Update: Early Thienopyridine Treatment to Improve Primary PCI in Patients With Acute MI [Phase 3]

View source ↗

Summary

Phase 3 trial update on early thienopyridine treatment to improve outcomes during primary PCI in patients with acute myocardial infarction, including STEMI, now…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• St-elevation Myocardial Infarction

Snippet

Sponsor: Stiftung Institut fuer Herzinfarktforschung | Conditions: Myocardial Infarction, STEMI | Phase 3 | Status: COMPLETED